The IL-17 family of cytokines - Application in respiratory medicine and allergology

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 2, Issue 2, 2008, Pages 82-91

  Laan, Martti ^a   Linden, Anders ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b Institute of Medicine   (Sweden)

Author keywords

Airway; Eosinophil; IL 17; IL 25; Lung; Neurophil

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 17A; INTERLEUKIN 17B; INTERLEUKIN 17C; INTERLEUKIN 17F; INTERLEUKIN 25; INTERLEUKIN 27; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ASTHMA; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MODEL; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; GENETIC POLYMORPHISM; GRANULOCYTE; HELPER CELL; HOST RESISTANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; LUNG DISEASE; NEUTROPHIL; ORGANIC DUST; PATENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; VASCULAR ENDOTHELIUM; VOLUNTEER;

ANIMALS; ASTHMA; DRUG DELIVERY SYSTEMS; GRANULOCYTES; HUMANS; INTERLEUKIN-17; PATENTS AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 55849103937     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221308784543683     Document Type: Review

References (104)

1. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14(5): 1015-1022.
2. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Resp Crit Care Med 1998; 157(5 Pt 1): 1498-1505.
3. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95(4): 843-852.
4. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986; 77(4): 527-537.
5. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000; 117(2): 10S-14S.
6. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100(6): 655-669.
7. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89(4): 587-596.
8. Ivanov, II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126(6): 1121-1133.
9. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
10. Gavett SH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Resp Cell Mol Biol 1994; 10(6): 587-593.
11. Nakajima H, Iwamoto I, Tomoe S, et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Review Resp Disease 1992; 146(2): 374-377.
12. Rutgers SR, Postma DS, ten Hacken NH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55(1): 12-18.
13. Turato G, Zuin R, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Resp Crit Care Med 2002; 166(1): 105-110.
14. Meshi B, Vitalis TZ, Ionescu D, et al. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Resp Cell Mol Biol 2002; 26(1): 52-57.
15. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150(12): 5445-5456.
16. Li H, Chen J, Huang A, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proceed Nat Acad of Sci USA 2000; 97(2): 773-778.
17. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002; 169(2): 642-646.
18. Lee J, Ho WH, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276(2): 1660-1664.
19. Kawaguchi M, Onuchic LF, Li XD, et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001; 167(8): 4430-4435.
20. Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001; 20(19): 5332-5341.
21. Wright JF, Guo Y, Quazi A, et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 2007; 282(18): 13447-13455.
22. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21(4): 467-476.
23. Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3(6): 811-821.
24. Linden A. A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling. Sci STKE 2007; (398): re4.
25. Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000; 275(25): 19167-19176.
26. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852.
27. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8(9): 942-949.
28. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proceed Nat Acad of Sci USA 2007; 104(43): 17034-17039.
29. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441(7090): 235-238.
30. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448(7152): 484-487.
31. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature immunol 2007; 8(12): 1390-1397.
32. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006; 27(1): 17-23.
33. Ivanov S, Bozinovski S, Bossios A, et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Resp Cell Mol Biol 2007; 36(4): 442-451.
34. Shin HC, Benbernou N, Esnault S, Guenounou M. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 1999; 11(4): 257-266.
35. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006; 177(7): 4662-4669.
36. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108(3): 430-438.
37. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170(4): 2106-2112.
38. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15(6): 985-995.
39. Ikeda K, Nakajima H, Suzuki K, et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003; 101(9): 3594-3596.
40. Kang CM, Jang AS, Ahn MH, et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Resp Cell Mol Biol 2005; 33(3): 290-296.
41. Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exper Med 2007; 204(8): 1837-1847.
42. Linden A, Hoshino H, Laan M. Airway neutrophils and interleukin-17. Eur Respir J 2000; 15(5): 973-977.
43. Laan M, Linden A. IL-17 as a potential target for modulating airway neutrophilia. Curr Pharm Des 2002; 8(20): 1855-1861.
44. Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir J 2005; 25(1): 159-172.
45. Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001; 126(3): 179-184.
46. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183(6): 2593-2603.
47. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162(4): 2347-2352.
48. Vanaudenaerde BM, Wuyts WA, Dupont LJ, Van Raemdonck DE, Demedts MM, Verleden GM. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22(11): 1280-1283.
49. Prause O, Laan M, Lotvall J, Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003; 462(1-3): 193-198.
50. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Resp Cell Mol Biol 2002; 26(6): 748-753.
51. Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000; 191(7): 1233-1240.
52. Laan M, Lotvall J, Chung KF, Linden A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharm 2001; 133(1): 200-206.
53. Kawaguchi M, Kokubu F, Kuga H, et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108(5): 804-809.
54. Henness S, Johnson CK, Ge Q, Armour CL, Hughes JM, Ammit AJ. IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol 2004; 114(4): 958-964.
55. Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160(7): 3513-3521.
56. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153(2): 530-534.
57. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol 1992; 149(9): 3078-3082.
58. Laan M, Prause O, Miyamoto M, et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J 2003; 21(3): 387-393.
59. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS. IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol 2006; 177(6): 4064-4071.
60. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/ autocrine loop. J Biol Chem 2003; 278(19): 17036-17043.
61. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003; 170(9): 4665-4672.
62. Hoshino H, Laan M, Sjostrand M, Lotvall J, Skoogh BE, Linden A. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 2000; 105(1 Pt 1): 143-149.
63. Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169(1): 443-453.
64. Happel KI, Dubin PJ, Zheng M, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005; 202(6): 761-769.
65. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes and infection/Institut Pasteur 2007; 9(1): 78-86.
66. Kleinschek MA, Muller U, Brodie SJ, et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006; 176(2): 1098-1106.
67. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infection Immunity. 2007; 75(6): 3055-3061.
68. Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature immunology. 2007; 8(4): 369-377.
69. Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol 2007; 292(2): L519-528.
70. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol 2007; 293(2): L505-515.
71. Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006; 203(12): 2715-2725.
72. Hellings PW, Kasran A, Liu Z, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Resp Cell Mol Biol 2003; 28(1): 42-50.
73. Sergejeva S, Ivanov S, Lotvall J, Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Resp Cell Mol Biol 2005; 33(3): 248-253.
74. Laan M, Palmberg L, Larsson K, Linden A. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002; 19(3): 534-537.
75. Ivanov S, Palmberg L, Venge P, Larsson K, Linden A. Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust. Resp Res 2005; 6: 44.
76. Larsson KA, Eklund AG, Hansson LO, Isaksson BM, Malmberg PO. Swine dust causes intense airways inflammation in healthy subjects. Am J Resp Crit Care Med 1994; 150(4): 973-977.
77. Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Resp Res 2006; 7: 135.
78. McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogenealpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175(1): 404-412.
79. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27(4): 779-787.
80. Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Resp Med 2003; 97(6): 726-733.
81. Kawaguchi M, Kokubu F, Matsukura S, et al. Induction of C-X-C chemokines, growth-related oncogene alpha expression, and epithelial cell-derived neutrophil-activating protein-78 by ML-1 (interleukin-17F) involves activation of Raf1-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase 1/2 pathway. J Pharmacol Exp Ther 2003; 307(3): 1213-1220.
82. Kawaguchi M, Kokubu F, Huang SK, et al. The IL-17F signaling pathway is involved in the induction of IFN-gamma-inducible protein 10 in bronchial epithelial cells. J Allergy Clin Immunol 2007; 119(6): 1408-1414.
83. Starnes T, Robertson MJ, Sledge G, et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001; 167(8): 4137-4140.
84. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Resp Crit Care Med 2005; 171(1): 12-18.
85. Suzuki S, Kokubu F, Kawaguchi M, et al. Expression of interleukin-17F in a mouse model of allergic asthma. Int Arch Allergy Immunol 2007; 143 Suppl 1: 89-94.
86. Kawaguchi M, Takahashi D, Hizawa N, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006; 117(4): 795-801.
87. Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204(7): 1509-1517.
88. Cheung PF, Wong CK, Ip WK, Lam CW. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy. 2006; 61(7): 878-885.
89. Letuve S, Lajoie-Kadoch S, Audusseau S, et al. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 2006; 117(3): 590-596.
90. Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176(2): 1013-1018.
91. Sharkhuu T, Matthaei KI, Forbes E, et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006; 36(12): 1575-1583.
92. Tamachi T, Maezawa Y, Ikeda K, et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 2006; 118(3): 606-614.
93. Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120(6): 1324-1331.
94. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203(4): 1105-1116.
95. Benson, J., Cunningham, M.: US20077247711 (2007).
96. Chirica, M., Kastelein, R.A., Moore, K.W., Parham, C.L.: US20046756481 (2004).
97. Shi, Y., Ruben, S.M.: US20026482923 (2002).
98. Rixon, M.W., Gao, Z., Levin, S.D., Stevens, B.L.: WO07117762A1: (2007).
99. Kuestner, R.E., Gao, Z., Levin, S.D., Rixon, M.W.: US20070196371A1 ( 2007).
100. Jaspers, S.R., Presnell, S.R., Rixon, M.W., Levin, S.D.: WO07106769A2 (2007).
101. Banchereau, J., Djossou, O., Flores-Romo, L., Fossiez, F., Golstein, P., Krishna, M., Lebecque, S.J.E., Murray, R.: US20006063372 (2000).
102. Jacobs, K., Kelleher, K., Carlin, M., Goldman, S., Pittman, D., Mi, S., Neben, S., Giannotti, J., Golden-Fleet, M.M.: US20056902735 (2005).
103. Hurst, S.D., Zurawski, S.M., Rennick, D.M.: US20046676939 (2004).
104. Chen, J., Filvaroff, E., Fong, S., Goddard, A., Godowski, P., Grimaldi, C., Gurney, A., Li, H., Hillan, K., Tumas, D., VanLookeren, M., Vandlen, R., Watanabe, C., Williams, P.M., Wood, W.I., Yansura, D.: US20036579520 (2003).